OOIR: Observatory of International Research

Papers

(The H4-Index of ERJ Open Research is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study	144
Type 2 inflammation in asthma and other airway diseases	98
Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members	82
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry	80
Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry	71
Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge	68
Increased blood angiotensin converting enzyme 2 activity in critically ill COVID-19 patients	55
Descriptive analysis of long COVID sequelae identified in a multidisciplinary clinic serving hospitalised and non-hospitalised patients	49
Underestimation of COVID-19 mortality during the pandemic	47
Evaluation of a multicomponent grading system for obstructive sleep apnoea: the Baveno classification	44
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis	41
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries	38
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characteris	38
INTREPID: single-versusmultiple-inhaler triple therapy for COPD in usual clinical practice	38
Radiological–pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways?	38
Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients	36
Breastfeeding and risk of childhood asthma: a systematic review and meta-analysis	35
Current and novel treatment options for obstructive sleep apnoea	35
Diaphragmatic motion recorded by M-mode ultrasonography: limits of normality	35
Characteristics and impact of exercise-induced laryngeal obstruction: an international perspective	34
Clinical and research priorities for children and young people with bronchiectasis: an international roadmap	34
Self-proning in COVID-19 patients on low-flow oxygen therapy: a cluster randomised controlled trial	33
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective	31
Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging	31
What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance	30

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes	29
ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group	29
International consensus on lung function testing during the COVID-19 pandemic and beyond	29
Prevalence, time trends and treatment practices of asthma in India: the Global Asthma Network study	28